<DOC>
	<DOCNO>NCT02644629</DOCNO>
	<brief_summary>The current study wish contribute applicability use ketamine clinical set focus efficacy intra-nasal administration compare IV route .</brief_summary>
	<brief_title>Intra-nasal vs. Intra-venous Ketamine Administration</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>1 . Age 1865 2 . Diagnosis MDD ( Major Depressive Disorder ) , make affirm senior psychiatrist Shalvata 3 . MADRS score &gt; 20 4 . Treated conventional antidepressant , administer within formal psychiatric clinic certify psychiatrist . 1 . Active past psychotic disorder , include history psychotic affective state 2 . Mental Retardation Autistic Spectrum Disorder 3 . Prominent personality disorder 4 . Cardiac neurologic active medical condition , include past CVA/TIA ( Cardiovascular Accident/Transient Ischemic Attack ) unstable medical condition . 5 . Chronic nasal congestion 6 . Active recent drug alcohol abuse 7 . Substantial suicidality patient require admission refuse , sign `` medical advice '' release form part clinical evaluation , answer term involuntary admission .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>